AMIX - AMIX

La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Autonomix Medical a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Autonomix Medical..

Autonomix Medical (NASDAQ:AMIX) Azioni, Catena delle Opzioni

Autonomix Medical

Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.

Autonomix Medical Inc

A crucial Navy server that stores vital pay and promotion data remains exposed without a disaster recovery plan after a contract to transfer the information to the cloud was canceled by the Department of Government Efficiency (DOGE).
What Happened: Earlier this month, DOGE terminated a $170 million contract with Pantheon, a firm tasked with transferring the Navy&#8217;s personnel data to a secure cloud platform. The transfer would have protected one of the last remaining Navy data centers, located in Tennessee, from threats like natural disasters. &#8220;Everything in terms of what sailors access, in terms of [the Navy&#8217;s online HR portal] would be impacted because they run on those mainframes,&#8221; a senior personnel official <a href="https://www.military.com/daily-news/2025/05/22/single-server-holds-all-navy-pay-and-promotion-data-doge-canceled-contract-upload-it-cloud.html">told</a> Military.com. &#8220;Reconstituting it would probably take anywhere between nine and 16 months, during which time we could not promote sailors effectively," he added.
See Also: <a href="https://www.benzinga.com/markets/25/05/45581565/us-treasury-pulls-the-plug-on-penny-production-after-231-years-eyes-56-million-in-immediate-annual-savings">US Treasury Pulls The Plug On Penny Production After 231 Years, Eyes $56 Million In Immediate Annual Savings</a>
Why It Matters: The aging system enables crucial HR tasks. Two months ago, a flooding incident almost caused major damage. Navy officials regarded Pantheon's initiative as a rare success amid the larger failure of the $1 billion Navy Pay and Personnel System (NP2), which is years behind schedule and still depends on 55 outdated systems.
While DOGE claims to be removing inefficiencies to save funds, this cut was misjudged, according to insiders. &#8220;You just shot the wrong target,&#8221; said a Navy official. Another source told Military.com that a DOGE representative had not reviewed the contract before canceling it.
This cancellation comes just as President Donald Trump, addressing service members stationed at Al Udeid Air Base, promised <a href="https://www.benzinga.com/general/25/05/45466418/trump-hails-us-troops-as-the-greatest-fighting-force-in-the-history-of-the-world-promises-pay-raises-for-each-and-every-one-of-you-and-vows-americas-military-will-soon-be-bigger-better-stronger-and-more-powerful-than-ever">"substantial pay raises"</a> for all military personnel. The GOP reconciliation bill, which passed the House this week, entails a <a href="https://www.benzinga.com/markets/equities/25/05/45217098/trumps-big-beautiful-bill-takes-shape-gop-pushes-tax-cuts-border-wall-funding-and-deep-spending-reductions-ahead-of-memorial-day-deadline">$150 billion package</a> for the Pentagon.
These developments come on the heels of a SIRI study revealing that in 2024,&nbsp;<a href="https://www.benzinga.com/25/04/45032800/global-defense-budgets-surge-to-27-trillion-as-europe-and-middle-east-lead-steepest-increase-since-cold-war-report" target="_blank" rel="noreferrer noopener">U.S. military expenditure touched $997 billion</a>, making up 66% of NATO&#8217;s total and 37% of global defense spending, which reached $2.7 trillion.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45582003/jamie-dimon-who-once-said-trump-was-right-about-some-of-china-now-reportedly-appears-to-be-siding-with-xi-jinping-amid-washington-beijing-tensions">Jamie Dimon, Who Once Said Trump Was &#8216;Right About Some Of China,&#8217; Now Reportedly Appears To Be Siding With Xi Jinping Amid Washington-Beijing Tensions</a></li>
</ul>
Photo courtesy: Tada Images / Shutterstock.com

News

Politics

DOGE Terminates Navy's $170 Million Cloud Backup Contract, Leaving Critical Pay And Promotion Data Vulnerable

On Thursday, May 22, U.S. markets closed mixed, easing Treasury yields helped offset earlier losses tied to deficit concerns. The House passed Trump's tax and spending bill, which fulfilled key campaign promises but significantly increased the national debt. Investors remain wary of ongoing uncertainty around tariffs and interest rates, which continue to weigh on market sentiment.
In economic data, U.S. initial jobless claims fell by 2,000 to 227,000 for the week ending May 17, below expectations of 230,000. The S&amp;P Global services PMI rose to 52.3 in May from 50.8, and the manufacturing PMI also climbed to 52.3 from 50.2 in April, indicating stronger economic momentum.
Most S&amp;P 500 sectors ended lower on Thursday, led by declines in utilities, health care, and energy. Consumer discretionary and communication services outperformed, closing higher.
The Dow closed flat at 41,859.09, the S&amp;P 500 dropped 0.04% to 5,842.01, while the Nasdaq gained 0.28% to 18,925.74.
Asia Markets Today
<ul class="wp-block-list">
<li>On Friday, Japan's Nikkei 225 closed 0.42% higher at 37,140.00, led by gains in the Real Estate, Banking, and Textile sectors.</li>
<li>Australia's S&amp;P/ASX 200 rose 0.15%, ending the session at 8,360.90, led by gains in the IT, Energy, and A-REITs sectors.</li>
<li>India's Nifty 50 was up 0.99% at 24,853.10, and Nifty 500 rose 0.83% to 22,781.55.</li>
<li>China's Shanghai Composite was down 0.94% at 3,348.37, and Shanghai Shenzhen CSI 300 slid 0.81% to 3,882.27.</li>
<li>Hong Kong's Hang Seng closed the session 0.24% higher at 23,601.26.</li>
</ul>
Eurozone at 05:45 AM ET
<ul class="wp-block-list">
<li>The European STOXX 50 index was down 0.10%.</li>
<li>Germany's DAX index gained 0.25%.</li>
<li>France's CAC 40 fell 0.35%.</li>
<li>U.K.'s FTSE 100 index traded higher by 0.19%.</li>
</ul>
Commodities at 05:45 AM ET
<ul class="wp-block-list">
<li>Crude Oil WTI was trading lower by 0.03% at $61.18/bbl, and Brent was down 0.03% at $64.42/bbl.</li>
<li>Natural Gas gained 1.48% to $3.301.</li>
<li>Gold was trading higher by 1.02% at $3,327.49, Silver was up 0.29% to $33.315, and Copper fell 1.02% to $4.7275.</li>
<li>Gold prices rose on safe-haven demand fueled by U.S. debt concerns and Middle East tensions.</li>
</ul>
U.S. Futures at 05:45 AM ET
Dow futures were down 0.13%, S&amp;P 500 futures declined 0.06%, and Nasdaq 100 futures fell 0.07%.
Forex at 05:45 AM ET
<ul class="wp-block-list">
<li>The U.S. Dollar Index declined 0.56% to 99.38, USD/JPY was down 0.47% to 143.35, and USD/AUD slid 0.83% to 1.5471.</li>
<li>The dollar fell for the week as U.S. debt concerns and Trump's tax bill spooked investors. Rising yields failed to stem outflows, boosting the euro and pressuring sentiment.</li>
</ul>
Photo via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

Markets

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Gold Up, Dollar Slides On Debt Concerns - Global Markets Today While US Slept

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth maintains Delcath Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCTH#NASDAQ">DCTH</a>) with a Buy and raises the price target from $24 to $29.

Price Target

Analyst Ratings

DCTH

HC Wainwright & Co. Maintains Buy on Delcath Systems, Raises Price Target to $29

OTLK

Outlook Therapeutics Prices $13M Public Offering Of Stock And Warrants At $1.40 Per Unit; Proceeds To Support Working Capital Needs

Net proceeds from the Transaction will be directed towards debt repayment to accelerate deleveraging efforts and strengthen Vermilion's balance sheet. Based on current strip commodity pricing(1) and operational plans, we would expect to exit 2025 with net debt(2) of $1.5&nbsp;billion, with a trailing net debt to FFO ratio(3) of 1.4&nbsp;times.

Vermilion Energy To Sell Saskatchewan And Manitoba Assets For $415M, Accelerate Debt Repayment

Lyondellbasell Declared Quarterly Dividend Of $1.37 Per Share, Representing $0.03 Per Share Increase Over Q1 Dividend; It Will Be Paid To Shareholders On June 9, 2025, With An Ex-dividend

Offerings

Gamehaus Holdings Filed Prospectus For Resale Of Up To 52.1M Class A Shares By Selling Shareholders

Modiv Says It Provided Clarity On Reverse Stock Split Proposal, Company Plans To Eliminate Dormant Accounts, And Cut Administrative Costs

Eason Technology Limited ("Eason Technology" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXF#NYSE">DXF</a>) today announced that it received a notice from NYSE Regulation indicating that the Company is not in compliance with the continued listing standards of NYSE American LLC ("NYSE American" or the "Exchange"). The Company failed to timely file its Form 20-F for the period ended December 31, 2024 (the "2024 Form 20-F") by the filing due date of May 15, 2025 (the "Filing Delinquency"). The Company is now subject to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide.
As disclosed in the Form 12b-25 filed by the Company on April 30, 2025, the Company was unable, without unreasonable effort or expense, to file its 2024 Form 20-F as a result of a delay in completing its financial statements for the period ended December 31, 2024. The Company was not able to make the required filing by May 15, 2025. The Company is making all efforts to file the 2024 Form 20-F as soon as possible and within the Initial Cure Period. However, there can be no assurance that the Company will ultimately regain compliance with all applicable Exchange listing standards.
This delinquency notice has no immediate impact on the listing of the Company's ADSs, which will continue to be listed and traded on the NYSE American during the cure period subject to continued compliance with the other listing requirements of the NYSE American.

Eason Technology Receives NYSE Non-Compliance Notice Following Delayed Filing of 2024 Form 20-F

<a href="https://www.reuters.com/world/us/us-panel-divided-over-nippon-steel-bid-us-steel-path-forward-seen-says-official-2025-05-22/" title="https://www.reuters.com/world/us/us-panel-divided-over-nippon-steel-bid-us-steel-path-forward-seen-says-official-2025-05-22/">https://www.reuters.com/world/us/us-panel-divided-over-nippon-steel-bid-us-steel-path-forward-seen-says-official-2025-05-22/</a>

Reuters Reported Earlier, National Security Panel Divided On Nippon Steel's Bid For U.S. Steel; Majority Say Risks Can Be Addressed, Citing White House Official

Benchmark analyst David Williams maintains Analog Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>) with a Buy and lowers the price target from $275 to $260.

Benchmark Maintains Buy on Analog Devices, Lowers Price Target to $260

The Donald Trump administration is making plans that could set the stage for deep-sea mining off the coast of American Samoa.
The move comes after an executive order from President Donald Trump aimed at quickening access to critical seabed resources in the interest of national security and economic development.
What Happened: On Tuesday, the Interior Department announced plans to begin a formal inquiry to assess industry and public interest in seabed mineral extraction near American Samoa, a U.S. territory in the South Pacific. According <a href="https://thehill.com/policy/energy-environment/5311881-trump-deep-sea-mining-american-samoa/">to</a> The Hill, this preliminary step, called a &#8220;request for information and interest," is meant to collect feedback from stakeholders like mining companies and the Indigenous Island community.
Interior Secretary Doug Burgum said, "By providing opportunities to responsibly access deep-sea mineral resources, we are supporting both <a href="https://www.benzinga.com/markets/25/04/45005825/us-has-tons-of-solutions-to-secure-rare-earth-production-if-china-halts-exports-experts-say-but-warn-of-significant-challenges">American economic growth</a> and national security."
See Also: <a href="https://www.benzinga.com/news/large-cap/25/05/45573883/walmart-cuts-1500-corporate-jobs-to-streamline-operations-amid-tariff-pressures">Walmart Cuts 1,500 Corporate Jobs To Streamline Operations Amid Tariff Pressures</a>
Why It Matters: According to the World Resources Institute, the aim of deep-sea mining is to "retrieve valuable mineral deposits found on the ocean&#8217;s floor, hundreds or even thousands of meters below its surface." The depths of the sea are home to a diverse range of marine life and contain "significant reserves of copper, cobalt, nickel, zinc, silver, gold, and rare earth elements."
While deep-sea mining <a href="https://www.benzinga.com/25/04/44835160/trump-orders-critical-minerals-probe-as-china-tightens-controls-over-rare-commodities">could reduce U.S. dependence on foreign supply chains</a>, environmental advocates warn that the practice may cause lasting ecological damage, including toxic sediment plumes, noise pollution, and irreversible harm to fragile marine ecosystems.
According to the World Wildlife Fund, only 1.1% of the knowledge needed to make science-based decisions about whether deep-seabed mining can go ahead is currently available.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/tech/25/05/45581375/microsoft-executive-says-companies-might-be-naming-ai-chiefs-but-they-risk-losing-momentum-in-the-artificial-intelligence-age-if-they-rely-on-individuals">Microsoft Executive Says Companies Might Be Naming &#8216;AI Chiefs&#8217; But They Risk Losing Momentum In The Artificial Intelligence Age If They Rely On Individuals</a></li>
</ul>
Photo courtesy: Joey Sussman / Shutterstock.com

Trump Administration Eyes Deep-Sea Mining Near American Samoa Amid Push For Critical Minerals

Keybanc analyst Ashley Owens downgrades Deckers Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) from Overweight to Sector Weight.

Downgrades

DECK

Keybanc Downgrades Deckers Outdoor to Sector Weight

The Federal Trade Commission has launched an investigation into Media Matters for America, escalating scrutiny over alleged coordination with watchdog groups to orchestrate advertiser boycotts against Elon Musk's social platform, X. What Happened: The FTC issued a civil investigative demand seeking documents related to Media Matters&#8217; communications with other organizations that monitor misinformation and hate speech, including the Global Alliance for Responsible Media, an initiative under the World Federation of Advertisers, reported Reuters, citing documents. 
Both groups are currently facing lawsuits from X.
The probe focuses on whether Media Matters helped facilitate ad pullbacks after Musk acquired Twitter (now X) in 2022. The watchdog has denied wrongdoing, calling the FTC's actions politically motivated, according to the report.
FTC Chairman Andrew Ferguson, a President Donald Trump appointee, signaled in December that the agency would pursue "unlawful collusion" between online platforms and advertisers. The House Judiciary Committee previously accused the Global Alliance of organizing an illegal group boycott. That initiative was dissolved in 2023.
See Also: <a href="https://www.benzinga.com/markets/25/05/45582003/jamie-dimon-who-once-said-trump-was-right-about-some-of-china-now-reportedly-appears-to-be-siding-with-xi-jinping-amid-washington-beijing-tensions">Jamie Dimon, Who Once Said Trump Was &#8216;Right About Some Of China,&#8217; Now Reportedly Appears To Be Siding With Xi Jinping Amid Washington-Beijing Tensions</a>
Why It Matters: The FTC's inquiry coincides with X&#8217;s expanded <a href="https://www.benzinga.com/tech/25/02/43420490/elon-musks-x-bolsters-antitrust-lawsuit-with-additional-advertisers">antitrust lawsuit against major advertisers</a> — including Nestlé, Abbott, and Colgate-Palmolive, alleging coordinated efforts to suppress ad spending. The outcome could set new precedents for how advertisers and platforms interact.
Media Matters President Angelo Carusone said, &#8220;These threats won&#8217;t work; we remain steadfast to our mission.&#8221; Meanwhile, concerns over platform bias persist: visibility for several X users dropped after they publicly criticized Musk, prompting <a href="https://www.benzinga.com/general/social-media/25/04/44973207/elon-musks-critics-on-x-see-sudden-drop-in-visibility-raising-questions-about-platforms-free-speech-commitments">questions over free speech enforcement</a>. 
Ad revenue on X is expected to rebound in 2025, but remains below pre-Musk levels, per Emarketer, the report noted. 
Image Via Shutterstock 
Read Also:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/global/25/05/45582741/g7-targets-chinas-state-driven-trade-tactics-without-naming-it-pledging-action-against-nonmarket-practices">G7 Targets China&#8217;s State-Driven Trade Tactics Without Naming It, Pledging Action Against &#8216;Nonmarket Practices&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Regulations

Social Media

Legal

Elon Musk's X Sparks FTC Probe Into Media Matters Over Ad Boycott Coordination With Watchdog Groups: Report

Earnings

MNSO

CORRECTION: MINISO Group Q1 EPS $0.26 Down From $0.27 YoY, Sales $610.06M Miss $624.52M Estimate. Earlier Headline Misstated Quarter As Q3

Wedbush analyst Daniel Ives maintains Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) with a Outperform and raises the price target from $350 to $500.

TSLA

Wedbush Maintains Outperform on Tesla, Raises Price Target to $500

Needham analyst Scott Berg reiterates Workday (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) with a Buy and maintains $300 price target.

Reiteration

WDAY

Needham Reiterates Buy on Workday, Maintains $300 Price Target

A post on Reddit&#8217;s r/WallStreetBets community is making waves after a user claimed to have made a bold, high-conviction stock play, risking not just financial ruin, but putting his marriage on the line.
What Happened: Friday early morning, a WallStreetBets user who goes by the name /u/Sensitive_Reveal_227 <a href="https://www.reddit.com/r/wallstreetbets/comments/1kt8b8d/i_took_100k_from_our_house_sale_and_bought_303/">posted</a> details surrounding his huge bet in the community.
He claims to have sold his house, clearing $120,000 in equity, of which he invested $100,000 into 303 shares of beleaguered health insurer, UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), all of which he did without informing his wife, and even outright misleading her.
&#8220;Wife said, ‘Put it somewhere safe.' I said, hold my beer,&#8221; he says, &#8220;Then funneled $100K into Fidelity and bought 303 shares of UnitedHealth.&#8221;
See Also: <a href="https://www.benzinga.com/markets/25/05/45582003/jamie-dimon-who-once-said-trump-was-right-about-some-of-china-now-reportedly-appears-to-be-siding-with-xi-jinping-amid-washington-beijing-tensions">Jamie Dimon, Who Once Said Trump Was &#8216;Right About Some Of China,&#8217; Now Reportedly Appears To Be Siding With Xi Jinping Amid Washington-Beijing Tensions</a>
While this would be a red flag in any marriage, the user insists he technically didn't lie. &#8220;Told the wife the money is safe in a high-yield savings account,&#8221; he added, &#8220;Technically not wrong.&#8221;
The thesis behind his investment is pretty straightforward: America's chronic health problems aren&#8217;t going away anytime soon. &#8220;Fat, old, diabetic, stressed out&#8230; healthcare is the last thing people cut,&#8221; he says, before noting the company&#8217;s scale and robust fundamentals.
The user also highlights recent insider buying in the stock, with the CEO, CFO, and independent directors all <a href="https://benzinga.com/general/health-care/25/05/45486314/unitedhealth-ceo-other-insiders-buy-millions-in-stock-as-it-sinks-over-23-in-a-week-move-gets-mixed-reaction">buying millions worth of shares</a> in the company, with their own personal money, which he views as a bullish signal.
The post concludes with a cheeky note on the user&#8217;s marital gamble, &#8220;Now I just need to convince her to stall on the purchase of our next home&#8230; Till death do us part,&#8221; he adds.
Why It Matters: UnitedHealth has found itself at the center of a perfect storm in recent months, starting <a href="https://www.benzinga.com/general/health-care/24/12/42316904/unitedhealthcare-ceo-brian-thompson-fatally-shot-outside-nyc-hotel">with the assassination</a> of its CEO Brian Thompson in December, which is now the subject of an investor lawsuit that alleges that the company downplayed the potential impact of this murder.
The company&#8217;s CEO, Andrew Witty, <a href="https://www.benzinga.com/25/05/45373368/unitedhealth-stock-plunges-names-new-ceo-suspends-2025-guidance">resigned abruptly last week</a>, further fueling uncertainty among investors, following which the current CEO, Stephen Hemsley, decided to suspend its full-year guidance. 
To top it off, just a few days later, a Wall Street Journal report claimed that UnitedHealth was <a href="https://benzinga.com/general/health-care/25/05/45424904/unitedhealth-stock-caught-in-a-perfect-storm-falls-nearly-50-since-april">under criminal investigation</a> by the U.S. Department of Justice, with a focus on the company&#8217;s Medicare Advantage business practices.
The company refuted all allegations, telling Benzinga that it has not been notified of any supposed criminal investigation by the DOJ, while calling WSJ&#8217;s reporting &#8220;deeply irresponsible.&#8221;
The stock has been on a steady decline since its disappointing first quarter results last month, down nearly 50% since then, despite a rebound this week, following news of <a href="https://benzinga.com/general/health-care/25/05/45486314/unitedhealth-ceo-other-insiders-buy-millions-in-stock-as-it-sinks-over-23-in-a-week-move-gets-mixed-reaction">insider buying activity</a>.
Price Action: The stock was down 2.08% on Thursday, trading at $296.67, but is up 1.33% after hours. It is down 41.20% on a year-to-date basis.
Since we&#8217;re talking about /r/WallStreetBets, it&#8217;s worth noting that GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) was up 10.02% on Thursday, due to rising Bitcoin prices, and is up 2.56% after hours.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="140" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23044556/Screenshot-2025-05-23-at-2.15.44-PM-1024x140.png" alt="" class="wp-image-925615" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23044556/Screenshot-2025-05-23-at-2.15.44-PM-1024x140.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23044556/Screenshot-2025-05-23-at-2.15.44-PM-300x41.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23044556/Screenshot-2025-05-23-at-2.15.44-PM-768x105.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23044556/Screenshot-2025-05-23-at-2.15.44-PM-1536x210.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23044556/Screenshot-2025-05-23-at-2.15.44-PM.png 1594w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
UnitedHealth scores poorly across the board in Benzinga&#8217;s Edge Stock Rankings. Click <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">here</a> for deeper insights into the stock, its peers, and competitors.
Read More:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45582025/stock-market-is-underpricing-downside-risks-of-the-tariff-rates-warns-expert-tariff-policy-nuances-are-far-more-important-than-the-one-big-beautiful-bill">Stock Market Is Underpricing &#8216;Downside Risks Of The Tariff Rates,&#8217; Warns Expert: Tariff Policy Nuances Are &#8216;Far More Important&#8217; Than The &#8216;One Big, Beautiful Bill&#8217;</a></li>
</ul>
Photo courtesy: Piotr Swat / Shutterstock.com

Health Care

WallStreetBets Redditor Says He Dropped $100K Into UnitedHealth After Selling His House Without Telling His Wife: 'Hold My Beer'

Renowned tech bull Dan Ives has significantly raised his price target for Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) to $500, signaling a strong bullish outlook driven by the imminent arrival of what he terms the &#8220;golden age of autonomous&#8221; vehicles.
What Happened: Ives conveyed his updated stance via an X post, emphasizing the pivotal role of upcoming developments for the electric vehicle giant.
&#8220;We believe the golden age of autonomous is now on the doorstep for Tesla with the Austin launch next month kicking off this key next chapter of growth for Musk &amp; Co.,&#8221; stated Ives.
His revised price target reflects an anticipation of substantial future value creation for the company. &#8220;we are raising our price target to $500 reflecting this massive stage of valuation creation ahead,&#8221; Ives added, underscoring the profound impact he expects autonomous technology to have on Tesla&#8217;s market capitalization.
The price target for the company stood at $350 per share before the update, thus representing a 42.85% increase.
The &#8220;Austin launch&#8221; next month appears to be a key catalyst in Ives&#8217; assessment, suggesting that the expansion of Tesla&#8217;s autonomous capabilities and related initiatives from its Austin facility will be a major driver of this new growth phase for Elon Musk&#8216;s enterprise.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We believe the golden age of autonomous is now on the doorstep for Tesla with the Austin launch next month kicking off this key next chapter of growth for Musk &amp; Co. and we are raising our price target to $500 reflecting this massive stage of valuation creation ahead. &#x1f525;&#x1f3c6;&#x1f402;&#x1f37f;&#x1f3c5;
&mdash; Dan Ives (@DivesTech) <a href="https://twitter.com/DivesTech/status/1925841823282393561?ref_src=twsrc%5Etfw">May 23, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/05/45582025/stock-market-is-underpricing-downside-risks-of-the-tariff-rates-warns-expert-tariff-policy-nuances-are-far-more-important-than-the-one-big-beautiful-bill">Stock Market Is Underpricing &#8216;Downside Risks Of The Tariff Rates,&#8217; Warns Expert: Tariff Policy Nuances Are &#8216;Far More Important&#8217; Than The &#8216;One Big, Beautiful Bill&#8217;</a>
Why It Matters: According to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>, Tesla shares are trading at a price nearly 158.730 times its 2026 earnings. At the same time, the average <a href="https://www.benzinga.com/general/market-summary/25/05/45539236/tesla-is-6x-more-expensive-than-its-peers-and-the-most-overvalued-mag-7-stock-gordon-johnson-questions-fundamentals-as-elon-musk-shrugs-off-concerns">forward price-to-earnings</a> of its peers stood at 25.75 times, implying that Tesla was 6.16 times more expensive than its industry&#8217;s average. 
The shares were down 10.08% year-to-date, but it has returned by 36.01% just in the last month. TSLA was up 96.29% over the year. On Thursday, it ended 1.92% higher, and it advanced 1.40% in premarket on Friday.
Meanwhile, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were flat in premarket on Friday. The SPY was down 0.026% to $583.00, while the QQQ declined 0.099% to $513.52, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
TSLA has a consensus ‘hold&#8217; with a consensus price target of $292.93, according to the <a href="https://www.benzinga.com/quote/TSLA/analyst-ratings">27 analysts tracked by Benzinga</a>. The targets range from $19.05 to $500. Recent ratings by Mizuho, Wedbush, and Guggenheim suggest a $303.33 target, implying a 12.26% downside.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/TSLA/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="388" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061100/ANR-TESLA-1024x388.png" alt="" class="wp-image-925741" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061100/ANR-TESLA-1024x388.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061100/ANR-TESLA-300x114.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061100/ANR-TESLA-768x291.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061100/ANR-TESLA.png 1396w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Benzinga Edge Stock Rankings shows that Tesla had a stronger price trend over the short, medium, and long term. Its momentum ranking was solid, however, its value ranking was poor at the 8.76th percentile. The details of other metrics are <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">available here</a>.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="140" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061035/EDGE-Tesla-new-1024x140.png" alt="" class="wp-image-925739" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061035/EDGE-Tesla-new-1024x140.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061035/EDGE-Tesla-new-300x41.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061035/EDGE-Tesla-new-768x105.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23061035/EDGE-Tesla-new.png 1215w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/market-summary/25/05/45581555/growth-vs-value-expert-views-collide-on-the-impact-of-trumps-big-beautiful-bill">Growth Vs. Value: Expert Views Collide On The Impact Of Trump&#8217;s &#8216;Big, Beautiful&#8217; Bill</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. Image Via Shutterstock

Analyst Color

Equities

Market Summary

Broad U.S. Equity ETFs

ETFs

General

TSLA Stock Jumps In Friday Premarket As Wedbush's Dan Ives Raises Price Target To $500, Citing 'Golden Age Of Autonomous' Vehicles

Needham analyst Laura Martin reiterates Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>) with a Buy and maintains $14 price target.

NEXN

Needham Reiterates Buy on Nexxen International, Maintains $14 Price Target

Press Releases

Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain

Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology

Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR

Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor "What This Means" Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain

Autonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain

Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market

Autonomix CEO Brad Hauser to Present at Virtual Investor's Closing Bell Event

Autonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform Technology

AMIX

Aethlon Medical

Bluejay Diagnostics

Biomerica

Co-Diagnostics

Ekso Bionics Holdings, Inc. - Common Stock

Ekso Bionics Holdings

GlucoTrack

HeartSciences

Helius Medical Technologies, Inc. - Class A Common Stock

Helius Medical Tech

Intelligent Bio Solutions Inc. - Common Stock

Intelligent Bio Solutions

INVO Fertility

Know Labs

LogicMark

NanoVibronix

ENDRA Life Sciences

Nuwellis

Predictive Oncology

ReShape Lifesciences, Inc. - Common Stock

Reshape Lifesciences

SINTX Technologies

Strata Skin Sciences, Inc. - Common Stock

Strata Skin Sciences

Tivic Health Systems, Inc. - Common stock

Tivic Health Systems

Tenon Medical

Venus Concept

Catheter Precision

Xylo Technologies Ltd. - American Depositary Shares

Xylo Technologies

Maxim Group

Ladenburg Thalmann

Screenshot 2024-10-02 at 5.21.14 PM

Biotech

This Company Is Taking An Innovative, Non-Opioid Approach To Pain Management For Pancreatic Cancer

Screenshot 2024-07-11 at 9.17.30 PM

Autonomix&#39;s Trial Results Show Meaningful Reduction In Pain For Patients Suffering From Pancreatic Cancer

Screenshot 2024-06-12 at 6.28.14 PM

Movers & Shakers

Discover How This Company&#39;s Breakthrough Technology Might Be The Key To Transforming Pancreatic Cancer Pain Relief

Screenshot 2024-06-05 at 7.12.02 PM

This One Company Is Working On A Breakthrough Approach To Revolutionize Pain Management

Screenshot 2024-05-07 at 11.14.55 PM

3000x More Sensitive Than What Is On The Market – This Technology Moves The Needle

Screenshot 2024-04-10 at 6.42.30 PM

Autonomix Medical (NASDAQ: AMIX) Is Cracking the Code Of The Peripheral Nervous System With Its Breakthrough Technology To Treat Diseases

The Nervous System Is Central To The Body, Yet Limited CNS Diagnostic Tools Exist – This Company Wants To Change That

Comments

Autonomix Medical

Autonomix Medical (AMIX) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO